Cite
HARVARD Citation
Hojbjerg, J. et al. (2019). Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients. Lung cancer. pp. 92-96. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hojbjerg, J. et al. (2019). Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients. Lung cancer. pp. 92-96. [Online].